Publication date: Jul 10, 2025
These children were randomly split into two groups: one group received the nanoemulsion version of vitamin D3, while the other group was given a commonly available standard supplement. New research explores how a vitamin D3 nanoemulsion might help ease the primary symptoms of autism spectrum disorder (ASD) in young children. Both groups followed their respective treatments for a six-month period. Researchers evaluated the childrens vitamin D3 levels, social and adaptive behaviors, and language development both before and after the supplementation.
| Concepts | Keywords |
|---|---|
| Autism | Adaptive |
| Bioavailability | Asd |
| Cars | Autism |
| Month | Behaviors |
| Nanoemulsion | D3 |
| Form | |
| Group | |
| Groups | |
| Improvements | |
| Levels | |
| Nanoemulsion | |
| Outcomes | |
| Supplement | |
| Symptoms | |
| Vitamin |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | autism spectrum disorder |
| disease | MESH | neurodevelopmental disorders |
| disease | MESH | Autism |
| drug | DRUGBANK | Cholecalciferol |
Original Article
(Visited 6 times, 1 visits today)